Cannamedical® Brand Product Line Launches and as Such Provides a New Level of Transparency for Patients, Doctors and Pharmacists

COLOGNE, Germany–(BUSINESS WIRE)–Cannamedical^® Pharma GmbH, Germany’s leading independent
medical cannabis distributor, announces the launch of twelve GMP
certified ‘own-brand’ products. The first two of these products were
shipped to German pharmacies today. Cannamedical^® is the
first and only medicinal cannabis importer in Europe to guarantee
transparency and that flowers from a single variety of medicinal
cannabis are used in each of its individual products, thus ensuring a
reliable therapeutic effect for patients, doctors and pharmacists.

“We are proud to be the only German company with a wide range of
own-brand medical cannabis products. Last year, we worked closely with
experts to advance our product portfolio, which sets new standards for
transparency and therapy. The range is comprised of twelve new products
with exclusively homogeneous Indica-, Sativa-, Hydrid- and cannabidiol
(CBD)-rich flowers, in light, medium and forte categories of effects.
For the first time patients can be treated according to their specific
needs,” says David Henn, CEO of Cannamedical^®.

Until now, doctors prescribing medicinal cannabis flowers as
therapeutics have not been able to rely on a consistent effect.
Suppliers change the cannabis varieties in their products depending on
their availability and the tetrahydrocannabinol (THC)/ CBD profile,
therefore the therapeutic success of their products cannot be
consistently guaranteed. They fail to take into account the significant
effect of the different types of terpenes, a chemical compound in the
cannabis plant. Cannamedical^®’s medicines exclusively use one
cannabis variety per product and the terpene profiles are disclosed on
the packaging. As such Cannamedical^® provides reliable,
high-quality medication and creates new standards through product
transparency in the market for patients, doctors and pharmacists alike.

After extensive testing and quality control, the first two of the twelve
GMP-compliant Cannamedical^® brand products, CANNAMEDICAL
INDICA and CANNAMEDICAL HYBRID forte, are now available to pharmacies in
Germany. Cannamedicals complete product line will be available over the
next few months.

Photo of David Henn, CEO Cannamedical^® Pharma GmbH at:
https://cannamedical.de/foto-david-henn

About Cannamedical^® Pharma GmbH

At Cannamedical^® Pharma GmbH we are committed to educating
doctors, medical specialists and pharmacists thus helping them improve
their patients’ quality of life. The high quality products by
Cannamedical^® focus on helping people with chronic illnesses
to giving them a better quality of life with medicinal cannabis. We
import and process only high-quality medicinal cannabis products and
supply around 2,500 pharmacies and clinical facilities.

As well as providing medicinal cannabis products of the highest
standards, our focus is providing critical information to medical and
customer service professionals. Our production partners worldwide must
comply with the highest pharmaceutical quality standards – the so-called
GMP guidelines (Good Manufacturing Practice). With its quality
management, Cannamedical^® guarantees the highest product
standards. In being ourselves GDP-certified (Good Distribution Practice)
our entire supply chain is guaranteed, from the agricultural environment
all the way to the pharmacy. Cannamedical^® Pharma GmbH was
founded in 2016 and employs approximately 50 employees in Cologne. In
addition, Cannamedical^® operates subsidiaries in Canada and
the UK.

For more information, visit www.cannamedical.com.

Contacts

Press contact
Sandra Grußbach
E-mail: [email protected]
Phone:
+49 221 999 852 51